Construct: ORF ccsbBroad304_14312
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF007769.1_s304c1, BRDN0000402024
- Derived from:
- ccsbBroadEn_14312
- DNA Barcode:
- None
- Epitope Tag:
- V5
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- CAPS2 (84698)
Vector Information:
- Vector Backbone:
- pLX_304
- Pol II Cassette 1:
- PGK-BlastR
- Pol II Cassette 2:
- CMV-ccsbBroad304_14312
- Selection Marker:
- BlastR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 84698 | CAPS2 | calcyphosine 2 | XM_017020039.1 | 58.1% | 58% | 1_438del;454G>A |
2 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001286548.3 | 53.3% | 53.1% | 1_534del;550G>A |
3 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001355030.2 | 53.3% | 53.1% | 1_534del;550G>A |
4 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001355031.2 | 53.3% | 53.1% | 1_534del;550G>A |
5 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001355032.2 | 53.3% | 53.1% | 1_534del;550G>A |
6 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001355033.2 | 53.3% | 53.1% | 1_534del;550G>A |
7 | human | 84698 | CAPS2 | calcyphosine 2 | XM_017020036.1 | 53.3% | 53.1% | 1_534del;550G>A |
8 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001355026.2 | 42.6% | 42.5% | 1_819del;835G>A |
9 | human | 84698 | CAPS2 | calcyphosine 2 | XM_005269194.3 | 41.8% | 41.7% | 1_438del;454G>A;879_879delTins172 |
10 | human | 84698 | CAPS2 | calcyphosine 2 | XM_005269192.1 | 40% | 39.9% | 1_912del;928G>A |
11 | human | 84698 | CAPS2 | calcyphosine 2 | XM_011538888.1 | 40% | 39.8% | 1_915del;931G>A |
12 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001355025.2 | 38.5% | 38.4% | 1_972del;988G>A |
13 | human | 84698 | CAPS2 | calcyphosine 2 | XM_011538887.2 | 37.4% | 37.3% | 1_1020del;1036G>A |
14 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001355024.2 | 36.1% | 35.9% | 1_1080del;1096G>A |
15 | human | 84698 | CAPS2 | calcyphosine 2 | XM_024449226.1 | 35.9% | 35.8% | 1_1086del;1102G>A |
16 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001355023.2 | 35.7% | 35.6% | 1_1098del;1114G>A |
17 | human | 84698 | CAPS2 | calcyphosine 2 | XM_011538886.2 | 35.3% | 35.2% | 1_1116del;1132G>A |
18 | human | 84698 | CAPS2 | calcyphosine 2 | XM_006719649.2 | 34.9% | 34.8% | 1_1134del;1150G>A |
19 | human | 84698 | CAPS2 | calcyphosine 2 | XM_011538878.1 | 33.8% | 33.7% | 1_1194del;1210G>A |
20 | human | 84698 | CAPS2 | calcyphosine 2 | XM_011538889.3 | 33.8% | 33.7% | 1_1194del;1210G>A |
21 | human | 84698 | CAPS2 | calcyphosine 2 | XM_006719648.2 | 33.1% | 33% | 1_1230del;1246G>A |
22 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001355027.2 | 27.7% | 27.6% | 1_972del;988G>A;1413_1413delTins172 |
23 | human | 84698 | CAPS2 | calcyphosine 2 | NM_001286547.3 | 27.5% | 27.4% | 1_984del;1000G>A;1425_1425delTins172 |
24 | human | 84698 | CAPS2 | calcyphosine 2 | NM_032606.5 | 23.8% | 23.7% | 1_1230del;1246G>A;1671_1671delTins172 |
25 | human | 84698 | CAPS2 | calcyphosine 2 | XR_944789.1 | 17% | 1_1427del;1443G>A;2040_3585del | |
26 | human | 84698 | CAPS2 | calcyphosine 2 | NR_149156.2 | 14.5% | 1_681del;697G>A;1294_4207del | |
27 | human | 84698 | CAPS2 | calcyphosine 2 | NR_149155.2 | 14.4% | 1_709del;725G>A;1322_4235del | |
28 | human | 84698 | CAPS2 | calcyphosine 2 | NR_149161.2 | 14.2% | 1_755del;771G>A;1368_4281del | |
29 | human | 84698 | CAPS2 | calcyphosine 2 | NR_149159.2 | 13.2% | 1_1085del;1101G>A;1698_4611del | |
30 | human | 84698 | CAPS2 | calcyphosine 2 | NR_149158.2 | 13.2% | (many diffs) | |
31 | human | 84698 | CAPS2 | calcyphosine 2 | NR_149157.2 | 13.1% | 1_1113del;1129G>A;1726_4639del | |
32 | human | 84698 | CAPS2 | calcyphosine 2 | NR_149160.2 | 13% | 1_1145del;1161G>A;1758_4671del |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 69
- ORF end:
- 681
- ORF length:
- 612
- Sequence:
-
1 ggtctatata agcagagctc tctggctaac tgtcgggatc aacaagtttg tacaaaaaag 61 ttggcaccat ggaacaggag gataatataa tcattcaaga aaccaatgat aggctggtct 121 tcaaagcaat tcaagatgtg ctaaaagaaa aactacataa aagaggtgtt cgtattttga 181 ctggattggg aaaatatttt caacagttgg acaaggaagg aaatggactt ttagataagg 241 cagattttaa gcaagctcta aaagtgtttc acttagaagt gtctgaaaag gattttgagt 301 ctgcatggct aattctgaat gacaatggca atggcaaggt tgattatgga gaattcaaac 361 gtggtattat tggtgaaatg aatgaataca ggaaatcata tgttcgaaag gcctttatga 421 aactggattt caacaaaagt ggcagtgtgc ctattataaa cataagaaaa tgttactgtg 481 caaagaagca ttctcaagta atttcaggcc attcaacaga ggaagaaatc aaatcatcct 541 ttctagaaac attaaaagtt gcctgcagca agtctgatga agtgtcatat ggtgaatttg 601 aagattacta tgaaggttta agtataggaa tagtagatga tgaagacttt gttaacatct 661 tacgtactcc atgggggatt ttgccaactt tcttgtacaa agtggttggt aagcctatcc 721 ctaaccctct cctcggtctc gattctacgt agtaatgagc tagcgctaac cggtggcgcg 781 ttaagtcgac aatcaacctc tggatta